US FDA approves Kura-Kyowa's blood cancer therapy
13.11.2025
By Kamal Choudhury and Christy Santhosh (Reuters) -The U. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.